VENDUM BATTERIES INC.

CIK:0001426568|SEC Filings

Consolidated Statements of Operations (unaudited) (USD $)	3 Months Ended		9 Months Ended		34 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Consolidated Statements Of Operations [Abstract]
REVENUES	$ 0	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Professional fees	12,379	19,563	20,479	70,555	138,355
Consulting fees	0	41,506	24,612	250,331	736,114
Director compensation	15,000	0	15,000	0	15,000
General and administrative expenses	9,799	3,146	17,776	13,265	64,263
TOTAL OPERATING EXPENSES	37,178	64,215	77,867	334,151	953,732
NET LOSS FROM OPERATIONS	(37,178)	(64,215)	(77,867)	(334,151)	(953,732)
OTHER INCOME (EXPENSE)
Interest expense	0	(5,540)	(7,552)	(10,040)	(30,601)
Interest – amortization of debt discount	0	0	(10,833)	0	(96,696)
Change in value of derivative liability	48,561	0	50,781	0	96,696
Impairment of intellectual property	0	0	0	0	(500,000)
TOTAL OTHER INCOME (EXPENSE)	48,561	(5,540)	32,396	(10,040)	(530,607)
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES	11,278	(69,755)	(45,471)	(344,191)	(1,484,339)
PROVISION FOR INCOME TAXES	0	0	0	0	0
NET INCOME (LOSS)	$ 11,278	$ (69,755)	$ (45,471)	$ (344,191)	$ (1,484,333)
NET LOSS PER SHARE: BASIC AND DILUTED	$ 0.00	$ 0.00	$ 0.00	$ 0.00
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	567,712,257	500,499,965	538,527,173	500,499,965

Consolidated Statements of Cash Flows (unaudited) (USD $)	9 Months Ended		34 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (45,471)	$ (344,191)	$ (1,484,333)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of intellectual property	0	0	500,000
Shares issued for services	0	0	245,000
Amortization of debt discount	10,833	0	96,696
Change in fair value of derivative liability	(50,781)	0	(96,696)
Changes in assets and liabilities:
Increase (decrease) in accrued expenses	2,395	111,673	241,555
Increase (decrease) in accrued expenses – related party	0	84,478	46,359
Increase in accrued interest – related parties	5,872	10,039	22,211
Increase in accrued interest	1,680	0	8,390
Cash Flows Used in Operating Activities	(75,472)	(138,001)	(420,818)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid to acquire intellectual property	0	0	(10,000)
Cash Flows Used in Investing Activities	0	0	(10,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from (repayment to) due to director	0	(505)	0
Cash received for stock subscription receivable	0	0	2
Proceeds from convertible note payable	0	134,500	285,000
Proceeds from note payable	77,192	0	84,192
Proceeds from the sale of common stock	0	0	70,000
Cash Flows Provided by Financing Activities	77,192	133,995	439,194
Exchange rate effect on cash and cash equivalents	0	(1,685)	(4,813)
Net Increase (decrease) in Cash and Cash Equivalents	1,720	(5,691)	3,563
Cash and cash equivalents, beginning of period	1,843	21,766	0
Cash and cash equivalents, end of period	3,563	16,075	3,563
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	0	0	0
Income taxes paid	0	0	0
SUPPLEMENTAL NON-CASH TRANSACTIONS
Stock issued for stock subscription receivable	0	0	0
Note payable issued to acquire intellectual property	0	0	490,000
Convertible notes payable converted to common stock	0	0	730,000
Note payable settled in common stock	232,596	0	232,596
Common stock issued for deferred offering costs	0	0	170,000
Derivative liability and debt discount recorded in connection with convertible debt	$ 0	$ 0	$ 96,696

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 3,563	$ 1,843
Deferred offering costs	170,000	170,000
Total Current Assets	173,563	171,843
Other Asset
Intellectual property	0	0
Total Assets	173,563	171,843
Current Liabilities
Accrued expenses	216,555	239,160
Accrued expenses – related party	46,359	46,359
Accrued interest – related parties	13,615	16,339
Accrued interest	8,390	6,710
Due to director	0	0
Convertible notes payable - related parties	25,000	75,000
Convertible notes payable, net of debt discount	42,192	103,167
Derivative liability	0	50,781
Total Liabilities	352,111	537,516
Stockholders' Deficit
Common stock, par value $.001, 750,000,000 shares authorized, 638,192,832 and 523,934,496 shares issued and outstanding, respectively	638,192	523,934
Additional paid-in capital	672,406	554,068
Cumulative translation adjustment	(4,813)	(4,813)
Deficit accumulated during the development stage	(1,484,333)	(1,438,862)
Total Stockholders' Deficit	(178,548)	(365,673)
Total Liabilities and Stockholders' Deficit	$ 173,563	$ 171,843